Log in
Enquire now
DecImmune Therapeutics

DecImmune Therapeutics

A biotechnology company developing peptides and antibodies for inflammation and autoimmunity

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
AngelList URL
angel.co/decimmune-...herapeutics
B2X
B2B
B2B
0
Crunchbase URL
crunchbase.com/organiz...apeutics
DUNS Number
611658860
Email Address
contact@decimmune.com
0
Founder
‌
Francis Moore
0
‌
Michael Carroll
0
Industry
Biopharmaceutical
Biopharmaceutical
Biology
Biology
Biotechnology
Biotechnology
Autoimmune disease
Autoimmune disease
Technology
Technology
Investors
Astellas Venture Management
Astellas Venture Management
Broadview Ventures
Broadview Ventures
Amgen Ventures
Amgen Ventures
HealthCare Ventures
HealthCare Ventures
Latest Funding Round Date
February 26, 2013
Location
Boston
Boston
Cambridge, Massachusetts
Cambridge, Massachusetts
Patents Assigned (Count)
4
Pitchbook URL
pitchbook.com/profiles.../51032-08
Total Funding Amount (USD)
5,450,000
Official Website
decimmune.com
Wellfound ID
decimmune-therapeutics

Find more companies like DecImmune Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.